Résumé
Background: Individuals with COPD have increased sensitivity to traffic-related air pollution (TRAP) such as diesel exhaust (DE), but little is known about the acute effects of TRAP on exercise responses in COPD. Research Question: Does exposure before exercise to TRAP (DE titrated to 300 μg/m3 particulate matter < 2.5 μm in diameter [DE300]) show greater adverse effects on exercise endurance, exertional dyspnea, and cardiorespiratory responses to exercise in participants with mild to moderate COPD compared with former smokers with normal spirometry and healthy control participants? Study Design and Methods: In this double-blind, randomized, placebo-controlled, crossover study, 11 healthy control participants, nine former smokers without COPD, and nine former smokers with COPD were separately exposed to filtered air (FA) and DE300 for 2 h separated by a minimum of 4 weeks. Participants performed symptom-limited constant load cycling tests within 2.5 h of exposure with detailed cardiorespiratory and exertional symptom measurements. Results: A significant negative effect of TRAP on exercise endurance time was found in healthy control participants (DE300 vs FA, 10.2 ± 8.2 min vs 12.9 ± 9.5 min, respectively; P = .03), but not in former smokers without COPD (10.1 ± 6.9 min vs 12.2 ± 8.0 min, respectively; P = .57) or former smokers with COPD (9.8 ± 6.4 min vs 8.4 ± 6.6 min, respectively; P = .31). Furthermore, significant increases in inspiratory duty cycle and absolute end-expiratory and end-inspiratory lung volumes were observed, and dyspnea ratings were elevated at select submaximal measurement times only in healthy control participants. Interpretation: Contrary to our hypothesis, it was the healthy control participants, rather than the former smokers with and without COPD, who were negatively impacted by TRAP during exercise. Trial Registry: ClinicalTrials.gov; No.: NCT02236039; URL: www.clinicaltrials.gov
Langue d'origine | English |
---|---|
Pages (de-à) | 662-675 |
Nombre de pages | 14 |
Journal | Chest |
Volume | 161 |
Numéro de publication | 3 |
DOI | |
Statut de publication | Published - mars 2022 |
Note bibliographique
Funding Information:FUNDING/SUPPORT: Operating funding for this study came from the Canadian Respiratory Research Network (CRRN), Canadian Lung Association (CLA), British Columbia Lung Association (BCLA), and a Canadian Institutes of Health Research (CIHR) Clinical Rehabilitation New Investigator Award. N. S. was supported by fellowships from The University of British Columbia, CLA, CRRN, and BCLA. M. H. R. was supported by the CRRN, WorkSafe BC, and the Natural Sciences and Engineering Research Council (NSERC) of Canada. M. R. S. was supported by the Michael Smith Foundation for Health Research (MSFHR) and BCLA. A. H. R. was supported by the NSERC and BCLA. J. M. L. was supported by the MSFHR Health Professional Investigator Award and the CIHR/AstraZeneca Early Career Investigator Award. C. J. R. was supported by the MSFHR. C. C. was supported by the MSFHR and the Canada Research Chairs Program. J. A. G. was supported by CIHR, MSFHR, CRRN, the Providence Health Care Research Institute and St. Paul's Hospital Foundation.
Publisher Copyright:
© 2021 American College of Chest Physicians
ASJC Scopus Subject Areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
PubMed: MeSH publication types
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't